U.S. Markets open in 5 hrs 1 min

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.77+0.32 (+5.87%)
At close: 04:00PM EDT
5.65 -0.12 (-2.08%)
Pre-Market: 04:04AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.45
Bid0.00 x 900
Ask0.00 x 1400
Day's Range5.43 - 5.82
52 Week Range2.87 - 17.85
Avg. Volume8,204,285
Market Cap404.519M
Beta (5Y Monthly)1.38
PE Ratio (TTM)N/A
EPS (TTM)-9.95
Earnings DateNov 03, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.33
  • Motley Fool

    Is This Growth Stock Undervalued?

    Biotech company Bluebird Bio (NASDAQ: BLUE) is currently riding high. Despite these accomplishments, Bluebird is still a tiny company with a market cap of just $475 million. Of note, Skysona had previously earned marketing authorization in Europe, but Bluebird exited the European market last year for reasons that may also prove to be a challenge in the U.S. (more on that in a bit).

  • Motley Fool

    Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?

    This drugmaker has earned two new drug approvals in as many months, but its success isn't reflected in its market valuation yet.

  • Zacks

    Bluebird (BLUE) Surges 15.7%: Is This an Indication of Further Gains?

    Bluebird (BLUE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.